Valuation: Lead Data Inc.

Market Cap 539M 16.73M 14.63M 13.49M 12.4M 23.5M 1.61B 23.9M 161M 63.21M 787M 62.83M 61.45M 2.71B P/E 2024
-3.97x
P/E 2025 -12.2x
Enterprise Value 568M 17.63M 15.42M 14.22M 13.07M 24.77M 1.7B 25.2M 170M 66.62M 829M 66.23M 64.78M 2.86B EV / Sales 2024
33.7x
EV / Sales 2025 5.13x
Free-Float
64.34%
Yield 2024 *
-
Yield 2025 -
3 years 2.27
Extreme 2.27
6.48
5 years 2.27
Extreme 2.27
6.48
10 years 1.89
Extreme 1.89
8.54
Manager TitleAgeSince
Chief Executive Officer - 17/08/2022
Director of Finance/CFO - 10/06/2022
Corporate Officer/Principal - 10/06/2022
Director TitleAgeSince
Director/Board Member - 10/06/2019
Chairman - 17/08/2022
Director/Board Member - 10/06/2022
Change 5-day change 1-year change 3-year change Capi.($)
-9.85%-.--%-.--%-0.28% 16.76M
+0.42%+4.81%+23.48%+8.72% 9.9B
-0.73%+21.24% - - 1.52B
+0.94%+1.18%+13.51%+2.52% 1.31B
-0.29%+2.08%+1.63%-11.63% 1.07B
+2.42%+5.05%+57.65%+32.13% 632M
+1.24%+8.72%-18.51%-55.50% 612M
-0.46%+4.55%+108.10%+162.15% 421M
+1.40%+4.03%-9.41%-12.45% 418M
+1.11%+15.46%-52.90%-81.02% 276M
Average -0.38%+3.96%+13.73%+4.96% 1.62B
Weighted average by Cap. +0.42%+3.20%+20.74%+7.11%

Financials

2024 2025
Net sales 15.47M 480K 420K 387K 356K 675K 46.21M 686K 4.62M 1.81M 22.59M 1.8M 1.76M 77.86M 111M 3.44M 3.01M 2.77M 2.55M 4.83M 331M 4.91M 33.1M 12.99M 162M 12.91M 12.63M 557M
Net income -134M -4.15M -3.63M -3.35M -3.08M -5.84M -400M -5.94M -40M -15.7M -195M -15.6M -15.26M -673M -44.02M -1.37M -1.2M -1.1M -1.01M -1.92M -132M -1.95M -13.16M -5.16M -64.29M -5.13M -5.02M -222M
Net Debt -16.95M -526K -460K -425K -390K -740K -50.66M -752K -5.07M -1.99M -24.76M -1.98M -1.93M -85.34M 29.12M 904K 791K 729K 670K 1.27M 87.01M 1.29M 8.71M 3.42M 42.53M 3.4M 3.32M 147M
Logo Lead Data Inc.
Lead Data Inc is a Taiwan-based company principally engaged in the trading business of medical equipment. The Company’s main products include continuous positive airway pressures (CPAP), hearing aids, oxygen concentrators, oxygen concentrators and rapid screening reagents for novel coronavirus pneumonia (COVID-19). CPAP can treat obstructive sleep apnea. It also has great benefits in improving sleep quality and solving snoring problems. The Company mainly operates in Taiwan and mainland China.
Employees
-
  1. Stock Market
  2. Stocks
  3. 2443 Stock